VoLox Eye Drop Special Precautions

General: In order to avoid emergence of resistant bacteria, bacterial susceptibility should be confirmed and treatment with this drug should be limited to the minimum period required for the eradication of the infection.
The efficacy of this product to Methicillin-resistant Staphylococcus aureus (MRSA) has not been proved. Therefore, other drug having a potent anti-MRSA activity should be administered immediately to patients positively infected with MRSA and not showing any improvement of symptoms with this product.
Use during pregnancy, delivery, or lactation: This product should be used in pregnant women or women who may possibly be pregnant only if the expected therapeutic benefits are judged to outweigh the possible risks associated with the treatment. (The safety of this product during pregnancy has not been established.)
Precautions concerning use: Route administration: ophthalmic use only.
At the time of administration: instruct the patient to be careful not to touch the tip of the bottle to the eye directly in order to avoid the contamination of the drug.